ZURA BIO LTDZURA

Bearish

ASignal's systematic analysis rates ZURA as Bearish.

Reflects the latest available analysis · analyzed Sep 30, 2026

The case on ZURA

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Strong cash position with $205.13M in total cash and no debt
  • High liquidity ratios (current ratio: 12.90x, quick ratio: 12.57x)
  • Extremely oversold RSI at 14.61 suggesting potential price rebound
VS
Bear case
  • Negative operating and free cash flow ($-77.55M and $-48.82M respectively)
  • Negative return on equity (-51.01%) and return on assets (-31.23%)
  • No revenue or earnings growth data available, indicating immature or non-commercial stage
  • MACD below signal line with negative histogram, indicating ongoing downtrend
  • Lack of Reddit mentions and limited news coverage from mixed sources
Subscriber-only

See the full verdict on ZURA

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes ZURA

Most investors never get a second opinion, let alone several. ASignal runs ZURA past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

ZURA BIO LTD (ZURA) Stock Analysis - ASignal rates it Bearish